Literature DB >> 30095493

Spectral Domain Anterior Segment Optical Coherence Tomography in Fungal Keratitis.

Namrata Sharma, Deepali Singhal, Prafulla Kumar Maharana, Tushar Agarwal, Rajesh Sinha, Gita Satpathy1, Lalit Mohan Singh Bageshwar, Jeewan S Titiyal.   

Abstract

PURPOSE: To evaluate the use of spectral domain anterior segment optical coherence tomography (SD-ASOCT) in fungal keratitis.
METHODS: Fifty eyes of 50 patients with fungal keratitis were recruited. Serial ASOCT was performed on days 0, 7, 14, 21, 28, 42, and 56. Corneal thickness (CT) in the infiltrate area, infiltrate thickness (IT), and infiltrate width were measured at each follow-up. The presence of any specific feature on ASOCT was evaluated.
RESULTS: Mean CT and IT at presentation were 650.5 ± 108 μm and 401.1 ± 91 μm, which reduced significantly at each follow-up [on days 7, 14, 28, and 42; 626.8 ± 113 μm (P < 0.001) and 367.3 ± 94 μm (P = 0.002), 601.4 ± 109 μm and 344.7 ± 94 μm (P < 0.001), 544.8 ± 103 μm and 305.1 ± 80 μm (P < 0.001), and 522.8 ± 97 μm and 291.4 ± 79 μm (P < 0.001), respectively]. The mean CT and scar depth at complete healing were 496.3 ± 101 μm and 283.2 ± 77 μm, respectively. In 10/50 (20%) eyes, the posterior border of the cornea was not clearly visible because of posterior shadowing; therefore, IT was measured along the maximum visible area of hyperreflectivity, whereas CT was measured just adjacent to the area of shadowing. The infiltrate width was measured in 35 eyes, and the mean values at days 0, 7, 14, 28, 42, and 56 were 5.5 ± 0.8 mm, 4.6 ± 0.7 mm, 4.4 ± 0.6 mm, 4.2 ± 0.6 mm, 4.1 ± 0.6 mm, and 4.1 ± 0.6 mm, respectively. A satellite lesion and endothelial plaque were seen in 30% (15/50) and 44% (22/50) eyes, respectively.
CONCLUSIONS: ASOCT is a useful adjunct in monitoring fungal keratitis especially in cases with deep stromal involvement and endothelial plaques. In addition, it also provides insight into the activity of keratitis.

Entities:  

Mesh:

Year:  2018        PMID: 30095493     DOI: 10.1097/ICO.0000000000001715

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

Review 1.  Post-keratoplasty Infectious Keratitis: Epidemiology, Risk Factors, Management, and Outcomes.

Authors:  Anna Song; Rashmi Deshmukh; Haotian Lin; Marcus Ang; Jodhbir S Mehta; James Chodosh; Dalia G Said; Harminder S Dua; Darren S J Ting
Journal:  Front Med (Lausanne)       Date:  2021-07-07

2.  In Vivo Confocal Microscopy and Anterior Segment Optical Coherence Tomography Analysis of the Microcystic Keratitis.

Authors:  Michał Dembski; Anna Nowińska; Klaudia Ulfik; Sławomir Teper; Edward Wylęgała
Journal:  J Ophthalmol       Date:  2020-12-17       Impact factor: 1.909

3.  Role of Anterior Segment Optical Coherence Tomography in Monitoring Epidemic Keratoconjunctivitis.

Authors:  Dhouha Gouider; Asma Khallouli; Afef Maalej; Sana Khochtali; Moncef Khairallah
Journal:  J Curr Ophthalmol       Date:  2022-01-06

Review 4.  Diagnostic armamentarium of infectious keratitis: A comprehensive review.

Authors:  Darren S J Ting; Bhavesh P Gopal; Rashmi Deshmukh; Gerami D Seitzman; Dalia G Said; Harminder S Dua
Journal:  Ocul Surf       Date:  2021-11-13       Impact factor: 5.033

Review 5.  Role of AS-OCT in Managing Corneal Disorders.

Authors:  Nidhi Gupta; Akhil Varshney; Muralidhar Ramappa; Sayan Basu; Vito Romano; Manisha Acharya; Abha Gaur; Neha Kapur; Aastha Singh; Gaurav Shah; Isha Chaudhary; Nikunj Patel; Anil Tiwari; Anahita Kate; Virender Sangwan; Umang Mathur
Journal:  Diagnostics (Basel)       Date:  2022-04-07

6.  Photo-activated chromophore for infectious keratitis cross-linking and its efficacy as a treatment modality in managing microbial keratitis.

Authors:  Sanchita Saini; Satyaprakash Singh; Kshama Dwivedi; Sanskriti Singh; Santosh Kumar; Jagriti Rana
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

Review 7.  The Development and Clinical Application of Innovative Optical Ophthalmic Imaging Techniques.

Authors:  Palaiologos Alexopoulos; Chisom Madu; Gadi Wollstein; Joel S Schuman
Journal:  Front Med (Lausanne)       Date:  2022-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.